Search research articles
Contact Us
Filters
Showing results (81-90 of 132) with videos related to
Page
of 14
Sort By:
Acta Clinica Belgica
|
January 1, 1989
Autoimmune haemolytic anaemia associated with malignant peritoneal mesothelioma
D L Selleslag, R J Geraghty, T S Ganesan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 1, 1983
Effect of dose and schedule on pharmacokinetics of high-dose cytosine arabinoside in plasma and cerebrospinal fluid
M L Slevin, E M Piall, G W Aherne, et al.
British Journal of Cancer
|
March 1, 1988
Oral urea in the treatment of secondary tumours in the liver
P I Clark, M L Slevin, J A Webb, et al.
Clinical Pharmacology and Therapeutics
|
February 17, 2001
Randomized placebo-controlled trial of the activity of the morphine glucuronides
R T Penson, S P Joel, K Bakhshi, et al.
BMJ (Clinical Research Ed.)
|
September 10, 1988
BACUP--the first two years: evaluation of a national cancer information service
M L Slevin, Y Terry, N Hallett, et al.
Medical and Pediatric Oncology
|
January 1, 1982
A comparison of two schedules of cytosine arabinoside used in combination with adriamycin and 6-thioguanine in the treatment of acute myelogenous leukemia
M L Slevin, A Z Rohatiner, H S Dhaliwal, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1984
Delayed-release bleomycin. Comparative pharmacology of bleomycin oil suspension and bleomycin in saline
M L Slevin, V J Harvey, G W Aherne, et al.
European Journal of Cancer & Clinical Oncology
|
November 1, 1985
Variable bioavailability following repeated oral doses of etoposide
V J Harvey, M L Slevin, S P Joel, et al.
British Journal of Clinical Pharmacology
|
October 1, 1981
The pharmacokinetics of subcutaneous cytosine arabinoside in patients with acute myelogenous leukaemia
M L Slevin, E M Piall, G W Aherne, et al.
European Journal of Cancer & Clinical Oncology
|
March 1, 1986
A phase II study of tamoxifen in ovarian cancer
M L Slevin, V J Harvey, R J Osborne, et al.
Page
of 14
Search research articles
Search
Showing results (81-90 of 132) with videos related to
Sort By:
Page
of 14
Acta Clinica Belgica
|
January 1, 1989
Autoimmune haemolytic anaemia associated with malignant peritoneal mesothelioma
D L Selleslag, R J Geraghty, T S Ganesan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 1, 1983
Effect of dose and schedule on pharmacokinetics of high-dose cytosine arabinoside in plasma and cerebrospinal fluid
M L Slevin, E M Piall, G W Aherne, et al.
British Journal of Cancer
|
March 1, 1988
Oral urea in the treatment of secondary tumours in the liver
P I Clark, M L Slevin, J A Webb, et al.
Clinical Pharmacology and Therapeutics
|
February 17, 2001
Randomized placebo-controlled trial of the activity of the morphine glucuronides
R T Penson, S P Joel, K Bakhshi, et al.
BMJ (Clinical Research Ed.)
|
September 10, 1988
BACUP--the first two years: evaluation of a national cancer information service
M L Slevin, Y Terry, N Hallett, et al.
Medical and Pediatric Oncology
|
January 1, 1982
A comparison of two schedules of cytosine arabinoside used in combination with adriamycin and 6-thioguanine in the treatment of acute myelogenous leukemia
M L Slevin, A Z Rohatiner, H S Dhaliwal, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1984
Delayed-release bleomycin. Comparative pharmacology of bleomycin oil suspension and bleomycin in saline
M L Slevin, V J Harvey, G W Aherne, et al.
European Journal of Cancer & Clinical Oncology
|
November 1, 1985
Variable bioavailability following repeated oral doses of etoposide
V J Harvey, M L Slevin, S P Joel, et al.
British Journal of Clinical Pharmacology
|
October 1, 1981
The pharmacokinetics of subcutaneous cytosine arabinoside in patients with acute myelogenous leukaemia
M L Slevin, E M Piall, G W Aherne, et al.
European Journal of Cancer & Clinical Oncology
|
March 1, 1986
A phase II study of tamoxifen in ovarian cancer
M L Slevin, V J Harvey, R J Osborne, et al.
Page
of 14